Vagus Nerve Stimulation Paired With Rehabilitation for Upper Limb Motor Impairment and Function After Chronic Ischemic Stroke: Subgroup Analysis of the Randomized, Blinded, Pivotal, VNS-REHAB Device Trial
Jesse Dawson,Navzer D. Engineer,Steven C. Cramer,Steven L. Wolf,Rushna Ali,Michael W. O’Dell,David Pierce,Cecília N. Prudente,Jessica Redgrave,Wuwei Feng,Charles Y. Liu,Gerard E. Francisco,Benjamin L. Brown,Anand Dixit,Jen Alexander,Louis DeMark,Vibor Krishna,Steven A. Kautz,Arshad Majid,Brent Tarver,Duncan L. Turner,Teresa J. Kimberley
DOI: https://doi.org/10.1177/15459683221129274
2022-10-14
Neurorehabilitation and Neural Repair
Abstract:Neurorehabilitation and Neural Repair, Ahead of Print. BackgroundVagus Nerve Stimulation (VNS) paired with rehabilitation improved upper extremity impairment and function in a recent pivotal, randomized, triple-blind, sham-controlled trial in people with chronic arm weakness after stroke.ObjectiveWe aimed to determine whether treatment effects varied across candidate subgroups, such as younger age or less injury.MethodsParticipants were randomized to receive rehabilitation paired with active VNS or rehabilitation paired with sham stimulation (Control). The primary outcome was the change in impairment measured by the Fugl–Meyer Assessment Upper Extremity (FMA-UE) score on the first day after completion of 6-weeks in-clinic therapy. We explored the effect of VNS treatment by sex, age (≥62 years), time from stroke (>2 years), severity (baseline FMA-UE score >34), paretic side of body, country of enrollment (USA vs UK) and presence of cortical involvement of the index infarction. We assessed whether there was any interaction with treatment.FindingsThe primary outcome increased by 5.0 points (SD 4.4) in the VNS group and by 2.4 points (SD 3.8) in the Control group (P = .001, between group difference 2.6, 95% CI 1.03-4.2). The between group difference was similar across all subgroups and there were no significant treatment interactions. There was no important difference in rates of adverse events across subgroups.ConclusionThe response was similar across subgroups examined. The findings suggest that the effects of paired VNS observed in the VNS-REHAB trial are likely to be consistent in wide range of stroke survivors with moderate to severe upper extremity impairment.
clinical neurology,rehabilitation